Pfizer Gets $2.15 Billion Settlement on Protonix

Pfizer Gets $2.15 Billion Settlement on Protonix

JB Reed/Bloomberg.

Pfizer Inc. said a $2.15 billion settlement has been reached with Teva Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries Ltd. after an almost 10-year dispute over the sale of generic Protonix in the U.S.